{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T04:35:23Z","timestamp":1788669323586,"version":"build-2803163510"},"reference-count":64,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2024,6,1]]},"abstract":"Importance<\/jats:title>Psychomotor slowing is a frequent symptom of psychosis, impairing gross and fine motor behavior. It is associated with poor outcomes and functioning, and no treatment is available.<\/jats:p><\/jats:sec>Objective<\/jats:title>To investigate whether 15 sessions of inhibitory repetitive transcranial magnetic stimulation (rTMS) may reduce psychomotor slowing.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This was a 4-arm, double-blind, randomized, sham-controlled trial at a university hospital in Switzerland. Enrollment took place from March 2019 to August 2022. Adults aged 18 to 60 years with schizophrenia spectrum disorders and severe psychomotor slowing were eligible. All patients continued existing medications, including antipsychotics and benzodiazepines. Those with substance misuse (other than nicotine), conditions associated with impaired or aberrant movement, convulsions, history of hearing problems, other conditions typically excluded from magnetic resonance imaging or TMS, any TMS treatment in the past 3 months, or those who were pregnant or breastfeeding were excluded. Of 615 patients screened for eligibility, 103 were randomized and 88 received at least 1 session of rTMS: 22 were assigned to 1-Hz rTMS, 22 to iTBS, 22 to sham, and 22 to the waiting group. Follow-up was conducted at 6 weeks and 24 weeks following the week 3 assessments including clinical, functional, and motor measures.<\/jats:p><\/jats:sec>Interventions<\/jats:title>Fifteen sessions of rTMS in 3 weeks over the supplementary motor area: 1-Hz rTMS, iTBS, sham, or no treatment (waiting). After 3 weeks, the waiting group received 15 sessions of 1-Hz rTMS over the supplementary motor area.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The main outcome was the proportion of responders at week 3 in the Salp\u00eatri\u00e8re Retardation Rating Scale (SRRS) defined as a 30% or greater reduction from baseline (last-observation-carried-forward). The SRRS has 15 items and a maximum total score of 60.<\/jats:p><\/jats:sec>Results<\/jats:title>Of the 88 participants analyzed, 45 were men and 43 were women. The mean (SD) age was 36.3 (12.4) years and the mean (SD) SRRS score was 24.0 (5.9). A total of 69 participants completed the study. At week 3, response rates differed between groups: 15 of 22 (68%) in the 1-Hz rTMS group, 8 of 22 (36%) in the iTBS group, 7 of 22 (32%) in the sham group, and 4 of 22 (18%) in the waiting group (\u03c72<\/jats:sup>3<\/jats:sub>\u2009=\u200912.1; P<\/jats:italic>\u2009=\u2009.007). The 1-Hz rTMS group had more responders than sham (odds ratio [OR], 0.13; 95% CI, 0.02-0.65; P<\/jats:italic>\u2009=\u2009.03), iTBS (OR, 0.12; 95% CI, 0.02-0.61; P<\/jats:italic>\u2009=\u2009.02), and waiting (OR, 0.04; 95% CI, 0.01-0.22; P<\/jats:italic>\u2009=\u2009.003). In the waiting group, 10 of 16 participants (63%) responded after receiving 15 sessions of 1-Hz rTMS. No serious adverse events occurred.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this study, inhibitory add-on rTMS safely alleviated psychomotor slowing in psychosis compared with iTBS, sham, and no treatment. The treatment was also effective with delayed onset. Future studies need to explore the neural changes associated with supplementary motor area rTMS in psychosis.<\/jats:p><\/jats:sec>Trial Registration<\/jats:title>ClinicalTrials.gov Identifier: NCT03921450<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1001\/jamapsychiatry.2024.0026","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T16:35:28Z","timestamp":1709138128000},"page":"563","source":"Crossref","is-referenced-by-count":36,"title":["Psychomotor Slowing in Psychosis and Inhibitory Repetitive Transcranial Magnetic Stimulation"],"prefix":"10.1001","volume":"81","author":[{"given":"Sebastian","family":"Walther","sequence":"first","affiliation":[{"name":"Translational Research Center, University Hospital of Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danai","family":"Alexaki","sequence":"additional","affiliation":[{"name":"Translational Research Center, University Hospital of Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Weiss","sequence":"additional","affiliation":[{"name":"Translational Research Center, University Hospital of Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Baumann-Gama","sequence":"additional","affiliation":[{"name":"Translational Research Center, University Hospital of Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Kyrou","sequence":"additional","affiliation":[{"name":"Translational Research Center, University Hospital of Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie G.","family":"Nuoffer","sequence":"additional","affiliation":[{"name":"Translational Research Center, University Hospital of Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland"},{"name":"Graduate School for Health Sciences, University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"W\u00fcthrich","sequence":"additional","affiliation":[{"name":"Translational Research Center, University Hospital of Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland"},{"name":"Graduate School for Health Sciences, University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Lefebvre","sequence":"additional","affiliation":[{"name":"Translational Research Center, University Hospital of Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niluja","family":"Nadesalingam","sequence":"additional","affiliation":[{"name":"Translational Research Center, University Hospital of Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"10323","key":"yoi240002r1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S0140-6736(21)01730-X","article-title":"Schizophrenia.","volume":"399","author":"Jauhar","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"yoi240002r2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.schres.2013.04.039","article-title":"Structure of the psychotic disorders classification in DSM-5.","volume":"150","author":"Heckers","year":"2013","journal-title":"Schizophr Res"},{"key":"yoi240002r3","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.neubiorev.2021.11.027","article-title":"A systematic review of the prognostic value of motor abnormalities on clinical outcome in psychosis.","volume":"132","author":"Pieters","year":"2022","journal-title":"Neurosci Biobehav Rev"},{"key":"yoi240002r4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.euroneuro.2020.07.003","article-title":"Movement disorder and sensorimotor abnormalities in schizophrenia and other psychoses\u2014European consensus on assessment and perspectives.","volume":"38","author":"Walther","year":"2020","journal-title":"Eur Neuropsychopharmacol"},{"issue":"7","key":"yoi240002r5","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1017\/S0033291708004716","article-title":"Spontaneous movement disorders in antipsychotic-naive patients with first-episode psychoses: a systematic review.","volume":"39","author":"Pappa","year":"2009","journal-title":"Psychol Med"},{"issue":"8","key":"yoi240002r6","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1002\/mds.v25:8","article-title":"Motor behavior abnormalities in drug-na\u00efve patients with schizophrenia spectrum disorders.","volume":"25","author":"Peralta","year":"2010","journal-title":"Mov Disord"},{"issue":"4","key":"yoi240002r7","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1093\/schbul\/sbl051","article-title":"Psychomotor slowing in schizophrenia.","volume":"33","author":"Morrens","year":"2007","journal-title":"Schizophr Bull"},{"key":"yoi240002r8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bionps.2020.100016","article-title":"Psychomotor slowing in schizophrenia: implications for endophenotype and biomarker development.","volume":"2","author":"Osborne","year":"2020","journal-title":"Biomark Neuropsychiatry"},{"issue":"7","key":"yoi240002r9","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/S2215-0366(18)30474-7","article-title":"Structure and neural mechanisms of catatonia.","volume":"6","author":"Walther","year":"2019","journal-title":"Lancet Psychiatry"},{"issue":"19","key":"yoi240002r10","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1056\/NEJMra2116304","article-title":"Catatonia.","volume":"389","author":"Heckers","year":"2023","journal-title":"N Engl J Med"},{"key":"yoi240002r11","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2022.152307","article-title":"Motor abnormalities are associated with poor social and functional outcomes in schizophrenia.","volume":"115","author":"Nadesalingam","year":"2022","journal-title":"Compr Psychiatry"},{"issue":"3","key":"yoi240002r12","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1093\/schbul\/sbw126","article-title":"Relationship between objectively measured sedentary behavior and cognitive performance in patients with schizophrenia vs controls.","volume":"43","author":"Stubbs","year":"2017","journal-title":"Schizophr Bull"},{"key":"yoi240002r13","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.comppsych.2017.01.010","article-title":"Physical activity ameliorates the association between sedentary behavior and cardiometabolic risk among inpatients with schizophrenia: a comparison versus controls using accelerometry.","volume":"74","author":"Stubbs","year":"2017","journal-title":"Compr Psychiatry"},{"issue":"3","key":"yoi240002r14","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1055\/s-2005-864125","article-title":"Correlation of subjective well-being in schizophrenic patients with gait parameters, expert-rated motor disturbances, and psychopathological status.","volume":"38","author":"Putzhammer","year":"2005","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"yoi240002r15","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1093\/schbul\/sbac170","article-title":"The behavioral mapping of psychomotor slowing in psychosis demonstrates heterogeneity among patients suggesting distinct pathobiology.","volume":"49","author":"Nadesalingam","year":"2023","journal-title":"Schizophr Bull"},{"issue":"4","key":"yoi240002r16","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/acps.2012.126.issue-4","article-title":"Parsing the components of the psychomotor syndrome in schizophrenia.","volume":"126","author":"Docx","year":"2012","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"yoi240002r17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.pscychresns.2015.06.010","article-title":"Psychomotor symptoms of schizophrenia map on the cerebral motor circuit.","volume":"233","author":"Walther","year":"2015","journal-title":"Psychiatry Res"},{"issue":"5","key":"yoi240002r18","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1093\/schbul\/sbw140","article-title":"Resting-state hyperperfusion of the supplementary motor area in catatonia.","volume":"43","author":"Walther","year":"2017","journal-title":"Schizophr Bull"},{"issue":"5","key":"yoi240002r19","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1093\/schbul\/sbx091","article-title":"Aberrant hyperconnectivity in the motor system at rest is linked to motor abnormalities in schizophrenia spectrum disorders.","volume":"43","author":"Walther","year":"2017","journal-title":"Schizophr Bull"},{"issue":"7","key":"yoi240002r20","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1080\/14737175.2020.1775586","article-title":"What is the potential of neurostimulation in the treatment of motor symptoms in schizophrenia?","volume":"20","author":"Lefebvre","year":"2020","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"yoi240002r21","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/s41386-022-01453-8","article-title":"Assessing the mechanisms of brain plasticity by transcranial magnetic stimulation.","volume":"48","author":"Jannati","year":"2023","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"yoi240002r22","doi-asserted-by":"publisher","DOI":"10.1093\/schizbullopen\/sgaa020","article-title":"Inhibitory repetitive transcranial magnetic stimulation to treat psychomotor slowing: a transdiagnostic, mechanism-based randomized double-blind controlled trial.","volume":"1","author":"Walther","year":"2020","journal-title":"Schizophr Bull Open"},{"key":"yoi240002r23","first-page":"19","article-title":"The measurement of retardation in depression.","volume":"59","author":"Dantchev","year":"1998","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"yoi240002r24","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/j.clinph.2009.08.016","article-title":"Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research.","volume":"120","author":"Rossi","year":"2009","journal-title":"Clin Neurophysiol"},{"issue":"11","key":"yoi240002r25","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1016\/j.clinph.2014.05.021","article-title":"Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS).","volume":"125","author":"Lefaucheur","year":"2014","journal-title":"Clin Neurophysiol"},{"issue":"11","key":"yoi240002r26","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1002\/mds.v23:11","article-title":"High-frequency rTMS over the supplementary motor area for treatment of Parkinson\u2019s disease.","volume":"23","author":"Hamada","year":"2008","journal-title":"Mov Disord"},{"issue":"15","key":"yoi240002r27","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1212\/WNL.0b013e31828c2f66","article-title":"Supplementary motor area stimulation for Parkinson disease: a randomized controlled study.","volume":"80","author":"Shirota","year":"2013","journal-title":"Neurology"},{"issue":"Pt 9","key":"yoi240002r28","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1093\/brain\/120.9.1587","article-title":"Stimulation over the human supplementary motor area interferes with the organization of future elements in complex motor sequences.","volume":"120","author":"Gerloff","year":"1997","journal-title":"Brain"},{"issue":"2","key":"yoi240002r29","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.neuron.2004.12.033","article-title":"Theta burst stimulation of the human motor cortex.","volume":"45","author":"Huang","year":"2005","journal-title":"Neuron"},{"issue":"2","key":"yoi240002r30","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia.","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"issue":"2","key":"yoi240002r31","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1093\/schbul\/sbq059","article-title":"The brief negative symptom scale: psychometric properties.","volume":"37","author":"Kirkpatrick","year":"2011","journal-title":"Schizophr Bull"},{"issue":"2","key":"yoi240002r32","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/acp.1996.93.issue-2","article-title":"Catatonia. I. Rating scale and standardized examination.","volume":"93","author":"Bush","year":"1996","journal-title":"Acta Psychiatr Scand"},{"issue":"6","key":"yoi240002r35","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1001\/archpsyc.1976.01770060086012","article-title":"The global assessment scale. a procedure for measuring overall severity of psychiatric disturbance.","volume":"33","author":"Endicott","year":"1976","journal-title":"Arch Gen Psychiatry"},{"issue":"9","key":"yoi240002r36","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1176\/ajp.149.9.1148","article-title":"Revising axis V for DSM-IV: a review of measures of social functioning.","volume":"149","author":"Goldman","year":"1992","journal-title":"Am J Psychiatry"},{"issue":"6","key":"yoi240002r37","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1093\/schbul\/sbm014","article-title":"Development of a brief scale of everyday functioning in persons with serious mental illness.","volume":"33","author":"Mausbach","year":"2007","journal-title":"Schizophr Bull"},{"issue":"3","key":"yoi240002r38","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/schbul\/sbv161","article-title":"Self-evaluation of negative symptoms: a novel tool to assess negative symptoms.","volume":"42","author":"Dollfus","year":"2016","journal-title":"Schizophr Bull"},{"issue":"8","key":"yoi240002r39","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","article-title":"International physical activity questionnaire: 12-country reliability and validity.","volume":"35","author":"Craig","year":"2003","journal-title":"Med Sci Sports Exerc"},{"issue":"3","key":"yoi240002r40","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1093\/schbul\/sbt038","article-title":"Less structured movement patterns predict severity of positive syndrome, excitement, and disorganization.","volume":"40","author":"Walther","year":"2014","journal-title":"Schizophr Bull"},{"issue":"12","key":"yoi240002r41","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/mds.v23:12","article-title":"Poor dopaminergic response of impaired dexterity in Parkinson\u2019s disease: Bradykinesia or limb kinetic apraxia?","volume":"23","author":"Gebhardt","year":"2008","journal-title":"Mov Disord"},{"issue":"6","key":"yoi240002r42","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1093\/schbul\/sbv037","article-title":"Dose equivalents for second-generation antipsychotic drugs: the classical mean dose method.","volume":"41","author":"Leucht","year":"2015","journal-title":"Schizophr Bull"},{"issue":"3","key":"yoi240002r43","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3928\/0048-5713-19950301-09","article-title":"Toxicity and adverse consequences of benzodiazepine use.","volume":"25","author":"Ashton","year":"1995","journal-title":"Psychiatric Annals"},{"issue":"11","key":"yoi240002r44","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.biopsych.2014.10.009","article-title":"Left prefrontal high-frequency repetitive transcranial magnetic stimulation for the treatment of schizophrenia with predominant negative symptoms: a sham-controlled, randomized multicenter trial.","volume":"77","author":"Wobrock","year":"2015","journal-title":"Biol Psychiatry"},{"issue":"11","key":"yoi240002r45","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1176\/appi.ajp.2019.18101180","article-title":"Efficacy and safety of deep transcranial magnetic stimulation for obsessive-compulsive disorder: a prospective multicenter randomized double-blind placebo-controlled trial.","volume":"176","author":"Carmi","year":"2019","journal-title":"Am J Psychiatry"},{"issue":"11","key":"yoi240002r46","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1038\/s41386-018-0121-x","article-title":"Efficacy, tolerability, and cognitive effects of deep transcranial magnetic stimulation for late-life depression: a prospective randomized controlled trial.","volume":"43","author":"Kaster","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"yoi240002r47","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/archgenpsychiatry.2010.46","article-title":"Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial.","volume":"67","author":"George","year":"2010","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"yoi240002r48","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.brs.2020.02.016","article-title":"A randomized, double blind, sham-controlled trial of repetitive transcranial magnetic stimulation (rTMS) in the treatment of negative symptoms in schizophrenia.","volume":"13","author":"Kumar","year":"2020","journal-title":"Brain Stimul"},{"issue":"1","key":"yoi240002r49","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/ana.v85.1","article-title":"Challenges of differential placebo effects in contemporary medicine: the example of brain stimulation.","volume":"85","author":"Burke","year":"2019","journal-title":"Ann Neurol"},{"issue":"9","key":"yoi240002r50","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1001\/jamapsychiatry.2018.1483","article-title":"Effect of repetitive transcranial magnetic stimulation on treatment-resistant major depression in US veterans: a randomized clinical trial.","volume":"75","author":"Yesavage","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"yoi240002r51","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00221-010-2293-4","article-title":"Simply longer is not better: reversal of theta burst after-effect with prolonged stimulation.","volume":"204","author":"Gamboa","year":"2010","journal-title":"Exp Brain Res"},{"issue":"3-4","key":"yoi240002r52","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00429-023-02634-x","article-title":"A systematic review of the neurobiological effects of theta-burst stimulation (TBS) as measured using functional magnetic resonance imaging (fMRI).","volume":"228","author":"Kirkovski","year":"2023","journal-title":"Brain Struct Funct"},{"issue":"6","key":"yoi240002r53","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1002\/hbm.v40.6","article-title":"Critical role of glutamatergic and GABAergic neurotransmission in the central mechanisms of theta-burst stimulation.","volume":"40","author":"Li","year":"2019","journal-title":"Hum Brain Mapp"},{"issue":"7","key":"yoi240002r54","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1093\/cercor\/bht023","article-title":"Network connectivity and individual responses to brain stimulation in the human motor system.","volume":"24","author":"C\u00e1rdenas-Morales","year":"2014","journal-title":"Cereb Cortex"},{"issue":"20","key":"yoi240002r55","doi-asserted-by":"publisher","first-page":"6849","DOI":"10.1523\/JNEUROSCI.4993-13.2014","article-title":"Dose-dependent effects of theta burst rTMS on cortical excitability and resting-state connectivity of the human motor system.","volume":"34","author":"Nettekoven","year":"2014","journal-title":"J Neurosci"},{"issue":"7","key":"yoi240002r56","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1176\/appi.ajp.2018.18040429","article-title":"Cerebellar-prefrontal network connectivity and negative symptoms in schizophrenia.","volume":"176","author":"Brady","year":"2019","journal-title":"Am J Psychiatry"},{"key":"yoi240002r57","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.schres.2021.10.005","article-title":"Intermittent theta burst stimulation of cerebellar vermis enhances fronto-cerebellar resting state functional connectivity in schizophrenia with predominant negative symptoms: a randomized controlled trial.","volume":"238","author":"Basavaraju","year":"2021","journal-title":"Schizophr Res"},{"issue":"1","key":"yoi240002r58","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41537-021-00138-3","article-title":"Intermittent theta burst stimulation for negative symptoms of schizophrenia\u2014a double-blind, sham-controlled pilot study.","volume":"7","author":"Bation","year":"2021","journal-title":"NPJ Schizophr"},{"issue":"1","key":"yoi240002r59","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1001\/jamapsychiatry.2023.4290","article-title":"Mapping psychomotor behavior in the brain.","volume":"81","author":"Walther","year":"2024","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"yoi240002r60","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12916-022-02414-0","article-title":"Revisiting the seven pillars of RDoC.","volume":"20","author":"Morris","year":"2022","journal-title":"BMC Med"},{"issue":"2","key":"yoi240002r61","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1017\/S0033291718003033","article-title":"The utility of an RDoC motor domain to understand psychomotor symptoms in depression.","volume":"49","author":"Walther","year":"2019","journal-title":"Psychol Med"},{"key":"yoi240002r62","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-023-02327-1","article-title":"The neural signature of psychomotor disturbance in depression.","author":"W\u00fcthrich","year":"2023","journal-title":"Mol Psychiatry"},{"issue":"2","key":"yoi240002r63","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1176\/appi.ajp.2021.20101429","article-title":"Stanford neuromodulation therapy (snt): a double-blind randomized controlled trial.","volume":"179","author":"Cole","year":"2022","journal-title":"Am J Psychiatry"},{"issue":"8","key":"yoi240002r64","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1176\/appi.ajp.2019.19070720","article-title":"Stanford accelerated intelligent neuromodulation therapy for treatment-resistant depression.","volume":"177","author":"Cole","year":"2020","journal-title":"Am J Psychiatry"},{"key":"yoi240002r33","volume-title":"Recent Developments in Parkinson\u2019s Disease","author":"Fahn","year":"1987"},{"key":"yoi240002r34","first-page":"534","volume-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2815183\/jamapsychiatry_walther_2024_oi_240002_1716936110.98786.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T16:26:12Z","timestamp":1717604772000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2815183"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2024,6,1]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2024.0026","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,1]]}}}